Evaluating Drug Risk Using GAN and SMOTE Based on CFDA’s Spontaneous Reporting Data
Adverse drug reactions (ADRs) pose health threats to humans. Therefore, the risk re-evaluation of post-marketing drugs has become an important part of the pharmacovigilance work of various countries. In China, drugs are mainly divided into three categories, from high-risk to low-risk drugs, namely,...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
2021-01-01
|
| Series: | Journal of Healthcare Engineering |
| Online Access: | http://dx.doi.org/10.1155/2021/6033860 |